相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Single-cell RNA-seq identification of four differentially expressed survival-related genes by a TARGET: Osteosarcoma database analysis
Mesalie Feleke et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2022)
Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma
Mesalie Feleke et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2022)
12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database
Emel Rothzerg et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2021)
Current research progress in targeted anti-angiogenesis therapy for osteosarcoma
Yun Liu et al.
CELL PROLIFERATION (2021)
Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma
Yun Liu et al.
FRONTIERS IN ONCOLOGY (2021)
Survival of osteosarcoma patients following diagnosis of synchronous skip metastases
Peiming Yang et al.
JOURNAL OF ORTHOPAEDICS (2020)
Blood-borne biomarkers of osteosarcoma: A systematic review
Gerald J. S. Tan et al.
PEDIATRIC BLOOD & CANCER (2019)
Early Diagnosis: A Seeming Misfortune for Osteosarcoma of Mandible-Rare Case Report
Ashvin Wagh et al.
INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY (2019)
PET/CT in the diagnosis and prognosis of osteosarcoma
Xiaojuan Zhang et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
PDGF/PDGFR effects in osteosarcoma and the add-on strategy
Jie Xu et al.
CLINICAL SARCOMA RESEARCH (2018)
Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs
Ying Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data
Hai-Yong Ren et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The structure of the death receptor 4-TNF-related apoptosis-inducing ligand (DR4-TRAIL) complex
Vidhyashankar Ramamurthy et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2015)
Review of the Molecular Pathogenesis of Osteosarcoma
Jin-Peng He et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Getting TRAIL back on track for cancer therapy
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
Death receptor agonist therapies for cancer, which is the right TRAIL?
Pamela M. Holland
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Translational biology of osteosarcoma
Maya Kansara et al.
NATURE REVIEWS CANCER (2014)
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
Marieke L. Kuijjer et al.
BMC CANCER (2013)
Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data
Marieke L. Kuijjer et al.
GENES CHROMOSOMES & CANCER (2012)
Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling
Aurelie Rossin et al.
BIOCHEMICAL JOURNAL (2009)
Barriers to effective TRAIL-targeted therapy of malignancy
Martin J. S. Dyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Osteosarcoma (Osteogenic sarcoma)
Piero Picci
ORPHANET JOURNAL OF RARE DISEASES (2007)
The promise of TRAIL - potential and risks of a novel anticancer therapy
Ronald Koschny et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Expression and function of TNF-family proteins and receptors in human osteoblasts
RF Bu et al.
BONE (2003)
Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy
S Bouralexis et al.
BRITISH JOURNAL OF CANCER (2003)
Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis
GJ Atkins et al.
BONE (2002)
Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRIAL-induced apoptosis
A Evdokiou et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
K Takeda et al.
NATURE MEDICINE (2001)
Temperature-sensitive differential affinity of TRAIL for its receptors - DR5 is the highest affinity receptor
A Truneh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)